drugset / Trial / NCT00000510

Platelet-Inhibitor Drug Trial in Coronary Angioplasty

NCT00000510 ↗

RandomizedDouble-blindPrevention

Summary

To determine the effectiveness of dipyridamole and aspirin in prevention of restenosis of the dilated lesion in patients who had undergone percutaneous transluminal coronary angioplasty (PTCA). Secondary aims were to determine the effectiveness of platelet inhibitor therapy in reducing the incidence of coronary events and the severity and incidence of angina.

Timeline

Start
1983-09
Primary completion
—
Completion
1988-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule — —
Subject Dipyridamole Other / unclassified — —